The Patent Finder

Impax Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Impax Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to Impax Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,602,521Multiplex drug delivery system suitable for oral administration
Formerly held
Term ended
Term ended Sep 29, 2018 · USPTO record
Term endedTerm ended Sep 29, 2018USPTO record
US 6,730,321Press Coated, Pulsatile Drug Delivery System Suitable for Oral Administration
Held by another company
Term ended
Ended no later than Jun 13, 2018 · Low confidence
Term endedEnded no later than Jun 13, 2018Low confidence
US 6,372,254Press coated, pulsatile drug delivery system suitable for oral administration
Formerly held
Term ended
Term ended Apr 2, 2018 · USPTO record
Term endedTerm ended Apr 2, 2018USPTO record
US 5,885,616Sustained release drug delivery system suitable for oral administration
Formerly held
Term ended
Term ended no later than Mar 23, 2019 · Low confidence
Term endedTerm ended no later than Mar 23, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited